The risk of saying “It’s just aging.” Every healthcare professional has seen it happen.
An older adult develops dizziness, fatigue, confusion, poor sleep, reduced appetite, or experiences a fall. The symptom is real, the concern is immediate, yet the explanation can come too quickly: it is probably just aging.
That assumption is understandable, but it is also where risk begins.
One of the most important and overlooked distinctions in medication management is the difference between an aging-related effect and a drug interaction. At first glance, the distinction seems straightforward. In practice, however, it is far more complex, especially in older adults, where physiology, comorbidity, and polypharmacy often intersect.
A simple distinction that becomes complicated in real life
An aging-related effect reflects how the body changes over time. Drug handling may shift. Sensitivity to a medication may increase. Organ function may decline. As a result, a dose that was once tolerated may no longer produce the same response.
A drug interaction, by contrast, occurs when one substance changes the effect of another. That may involve two medications, but it can also involve food, supplements, alcohol, or an underlying clinical condition. The result may be reduced effectiveness, greater toxicity, or an unexpected clinical response.
In theory, these are distinct concepts. In practice, older adults often experience both at once.
Why this matters beyond semantics
This is not just about using the right term. It is about avoiding the wrong conclusion.
Chronological age alone rarely explains medication risk. Renal function, hepatic function, frailty, cognition, hydration, nutrition, and total medication burden often tell us more about risk than chronological age does.
When clinicians attribute symptoms too quickly to age, they may overlook medication-related causes. That can delay intervention, contribute to prescribing cascades, increase fall risk, worsen cognitive burden, and create avoidable harm that a closer medication review might have prevented.
A practical example
Consider sedation.
If an older adult becomes more sensitive to a long-standing sedative over time, that may reflect an aging-related change in drug response. However, if the same patient becomes markedly more sedated after a second central nervous system depressant is added, a drug interaction is the more likely cause.
The outward symptom may look similar. The underlying mechanism may not. That distinction matters because the clinical response may differ as well. One case may call for reassessing dose appropriateness in light of age-related physiology. The other may require identifying and addressing the interacting factor. In many real-world cases, both issues deserve attention.
Why this matters for healthcare communicators
For clinicians, this issue affects assessment and prescribing. For pharmacists, it affects regimen review and medication safety. For medical affairs, patient education, and healthcare content teams, it affects how risk is framed and how audiences are taught to think.
The better question
Perhaps the most important shift is this:
The question is not always whether a symptom is caused by aging or by a drug interaction. The better question is whether enough review has taken place before concluding it is either one.
That shift may sound subtle, but it changes the posture of care. It moves the conversation away from assumption and toward assessment. In the care of older adults, that shift can make all the difference.